Patent details

Basic Information

Publication number:

EP2744827

PCT Application Number:

US2012051038

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127538734

PCT Publication Number:

WO2013028442

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-TIE2 ANTIBODIES USES THEREOF

French Title of Invention:

ANTICORPS ANTI-TIE2 ET UTILISATIONS ASSOCIÉES

German Title of Invention:

ANTI-TIE2-ANTIKÖRPER UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

16/08/2012

Grant date:

03/10/2018

EP Publication Date:

25/06/2014

PCT Publication Date:

28/02/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/10/2018

EP B1 Publication Date:

03/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/08/2019

Expiration date:

16/08/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/09/2018

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

Name:

THURSTON, Gavin

Address:

United States (US)

Priority

1

Priority Number:

201161525308 P

Priority Date:

19/08/2011

Priority Country:

United States (US)

2

Priority Number:

201261587213 P

Priority Date:

17/01/2012

Priority Country:

United States (US)

3

Priority Number:

201261674405 P

Priority Date:

23/07/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 35/00; C07K 14/705; C07K 14/71; C07K 16/28; C07K 16/40;

Publication

European Patent Bulletin

Issue number:

201840

Publication date:

03/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages